OMEROS CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
OMEROS CORP (OMER) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 2.91 million shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2023-11-09
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2023-09-30 was 2.71M shares, a 8.08% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2023-06-30 was 161.50K shares, a 50.02% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2023-03-31 was 38.50K shares, a 115.28% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-12-31 was 111.50K shares, a 247.62% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 2.74M shares, a 8.60% increase from fiscal 2021.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2021 was 2.53M shares, a 12.87% increase from fiscal 2020.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2020 was 2.24M shares, a 6.62% increase from fiscal 2019.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2019 was 2.10M shares, a 10.94% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2023-09-30 | 2.71M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 2.87M shares derived: sum of 2 quarters · filed 2023-11-09 | 2.91M shares 10-Q · filed 2023-11-09 | 3.02M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 161.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 200.00K shares 10-Q · filed 2023-08-09 | 311.50K shares derived: sum of 3 quarters · filed 2023-08-09 | 2.82M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 38.50K shares 10-Q · filed 2023-05-09 | 150.00K shares derived: sum of 2 quarters · filed 2023-05-09 | 2.66M shares derived: sum of 3 quarters · filed 2023-05-09 | 2.76M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 111.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 2.62M shares derived: sum of 2 quarters · filed 2023-03-13 | 2.72M shares derived: sum of 3 quarters · filed 2023-03-13 | 2.74M shares 10-K · filed 2023-03-13 |
| 2022-09-30 | 2.51M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 2.61M shares derived: sum of 2 quarters · filed 2022-11-09 | 2.63M shares 10-Q · filed 2022-11-09 | 2.66M shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 107.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 125.53K shares 10-Q · filed 2022-08-09 | 157.61K shares derived: sum of 3 quarters · filed 2022-08-09 | 2.34M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 17.88K shares 10-Q · filed 2022-05-10 | 49.96K shares derived: sum of 2 quarters · filed 2022-05-10 | 2.24M shares derived: sum of 3 quarters · filed 2022-05-10 | 2.30M shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 32.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 2.22M shares derived: sum of 2 quarters · filed 2022-03-01 | 2.28M shares derived: sum of 3 quarters · filed 2022-03-01 | 2.53M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 2.19M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 2.25M shares derived: sum of 2 quarters · filed 2021-11-09 | 2.49M shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 62.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 307.45K shares 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | 244.50K shares 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | 2.24M shares 10-K · filed 2021-03-01 | |||
| 2019-12-31 | 142.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 290.65K shares derived: sum of 2 quarters · filed 2020-03-02 | 492.20K shares derived: sum of 3 quarters · filed 2020-03-02 | 2.10M shares 10-K · filed 2020-03-02 |
| 2019-09-30 | 148.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 349.70K shares derived: sum of 2 quarters · filed 2019-11-12 | 1.96M shares 10-Q · filed 2019-11-12 | 2.16M shares derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | 201.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 1.81M shares 10-Q · filed 2019-08-08 | 2.01M shares derived: sum of 3 quarters · filed 2019-08-08 | 2.13M shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 1.61M shares 10-Q · filed 2019-05-09 | 1.81M shares derived: sum of 2 quarters · filed 2019-05-09 | 1.92M shares derived: sum of 3 quarters · filed 2019-05-09 | 3.42M shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | 199.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 316.95K shares derived: sum of 2 quarters · filed 2019-03-01 | 1.81M shares derived: sum of 3 quarters · filed 2019-03-01 | 1.89M shares 10-K · filed 2019-03-01 |
| 2018-09-30 | 117.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 1.61M shares derived: sum of 2 quarters · filed 2018-11-08 | 1.69M shares 10-Q · filed 2018-11-08 | 1.78M shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 1.49M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 1.57M shares 10-Q · filed 2018-08-09 | 1.67M shares derived: sum of 3 quarters · filed 2018-08-09 | 1.73M shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 80.55K shares 10-Q · filed 2018-05-10 | 170.80K shares derived: sum of 2 quarters · filed 2018-05-10 | 237.50K shares derived: sum of 3 quarters · filed 2018-05-10 | 430.39K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 90.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 156.95K shares derived: sum of 2 quarters · filed 2018-03-01 | 349.84K shares derived: sum of 3 quarters · filed 2018-03-01 | 1.83M shares 10-K · filed 2018-03-01 |
| 2017-09-30 | 66.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 259.59K shares derived: sum of 2 quarters · filed 2017-11-09 | 1.73M shares 10-Q · filed 2017-11-09 | 3.17M shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 192.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 1.67M shares 10-Q · filed 2017-08-08 | 3.10M shares derived: sum of 3 quarters · filed 2017-08-08 | 3.13M shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 1.48M shares 10-Q · filed 2017-05-10 | 2.91M shares derived: sum of 2 quarters · filed 2017-05-10 | 2.94M shares derived: sum of 3 quarters · filed 2017-05-10 | 3.25M shares derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | 1.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 1.47M shares derived: sum of 2 quarters · filed 2017-03-16 | 1.78M shares derived: sum of 3 quarters · filed 2017-03-16 | 3.13M shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 31.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 345.10K shares derived: sum of 2 quarters · filed 2016-11-09 | 1.69M shares 10-Q · filed 2016-11-09 | 1.78M shares derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | 314.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 1.66M shares 10-Q · filed 2016-08-09 | 1.75M shares derived: sum of 3 quarters · filed 2016-08-09 | 1.80M shares derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | 1.35M shares 10-Q · filed 2016-05-10 | 1.43M shares derived: sum of 2 quarters · filed 2016-05-10 | 1.48M shares derived: sum of 3 quarters · filed 2016-05-10 | 1.62M shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 85.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 132.65K shares derived: sum of 2 quarters · filed 2016-03-15 | 266.65K shares derived: sum of 3 quarters · filed 2016-03-15 | 350.98K shares 10-K · filed 2016-03-15 |
| 2015-09-30 | 47.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 181.40K shares derived: sum of 2 quarters · filed 2015-11-09 | 265.73K shares 10-Q · filed 2015-11-09 | 2.09M shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 134.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 218.32K shares 10-Q · filed 2015-08-10 | 2.04M shares derived: sum of 3 quarters · filed 2015-08-10 | 2.06M shares derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | 84.33K shares 10-Q · filed 2015-05-11 | 1.91M shares derived: sum of 2 quarters · filed 2015-05-11 | 1.92M shares derived: sum of 3 quarters · filed 2015-05-11 | 2.09M shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 1.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 1.84M shares derived: sum of 2 quarters · filed 2015-03-16 | 2.01M shares derived: sum of 3 quarters · filed 2015-03-16 | 2.01M shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 17.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 184.25K shares derived: sum of 2 quarters · filed 2014-11-10 | 184.25K shares 10-Q · filed 2014-11-10 | 393.25K shares derived: sum of 4 quarters · filed 2014-11-10 |
| 2014-06-30 | 166.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 166.75K shares 10-Q · filed 2014-08-11 | 375.75K shares derived: sum of 3 quarters · filed 2014-08-11 | 2.09M shares derived: sum of 4 quarters · filed 2014-08-11 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-12 | 209.00K shares derived: sum of 2 quarters · filed 2014-05-12 | 1.92M shares derived: sum of 3 quarters · filed 2014-05-12 | |
| 2013-12-31 | 209.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | 1.92M shares derived: sum of 2 quarters · filed 2014-03-13 | 1.94M shares 10-K · filed 2014-03-13 | |
| 2013-09-30 | 1.71M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 1.73M shares 10-Q · filed 2013-11-07 | ||
| 2013-06-30 | 25.00K shares 10-Q · filed 2013-08-09 | |||
| 2012-12-31 | 1.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 1.32M shares derived: sum of 2 quarters · filed 2013-03-18 | 2.56M shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 1.26M shares 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | 1.25M shares 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |